BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15994874)

  • 1. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
    Baser ME; Kuramoto L; Woods R; Joe H; Friedman JM; Wallace AJ; Ramsden RT; Olschwang S; Bijlsma E; Kalamarides M; Papi L; Kato R; Carroll J; Lázaro C; Joncourt F; Parry DM; Rouleau GA; Evans DG
    J Med Genet; 2005 Jul; 42(7):540-6. PubMed ID: 15994874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
    Kluwe L; MacCollin M; Tatagiba M; Thomas S; Hazim W; Haase W; Mautner VF
    Am J Med Genet; 1998 May; 77(3):228-33. PubMed ID: 9605590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further genotype--phenotype correlations in neurofibromatosis 2.
    Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
    Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
    Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
    Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
    Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.
    Abo-Dalo B; Kutsche K; Mautner V; Kluwe L
    Genes Chromosomes Cancer; 2010 Feb; 49(2):171-5. PubMed ID: 19924781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.
    Baser ME;
    Hum Mutat; 2006 Apr; 27(4):297-306. PubMed ID: 16521120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
    Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
    J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A point mutation associated with a severe phenotype of neurofibromatosis 2.
    MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
    Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation type and position varies between mosaic and inherited NF2 and correlates with disease severity.
    Evans DG; Bowers N; Huson SM; Wallace A
    Clin Genet; 2013 Jun; 83(6):594-5. PubMed ID: 22989157
    [No Abstract]   [Full Text] [Related]  

  • 14. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
    Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
    J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
    Baser ME; Kuramoto L; Joe H; Friedman JM; Wallace AJ; Gillespie JE; Ramsden RT; Evans DG
    Am J Hum Genet; 2004 Aug; 75(2):231-9. PubMed ID: 15190457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of novel NF2 mutations by an RNA mismatch cleavage method.
    Faudoa R; Xue Z; Lee F; Baser ME; Hung G
    Hum Mutat; 2000; 15(5):474-8. PubMed ID: 10790209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.